Pharma News

Idorsia Pharmaceuticals has petitioned the Drug Enforcement Administration (DEA) to deschedule dual orexin receptor antagonists (DORA), a class of chronic insomnia medications. ...

Administration (FDA) plans to hold a meeting of its outside experts in June to discuss full approval of the Alzheimer's drug developed by Eisai Co Ltd 4523.T and Biogen Inc BIIB.O, according to a f...

The companies’ decision is based on the recommendation from an independent data monitoring committee (DMC).

BioNTech and China-based Duality Biologics have inked a licensing and collaboration deal to develop two antibody-drug conjugates (ADCs).

New Delhi : India has seen extraordinary growth in the pharma industry and has reached from Zero to 13 per cent of the global market. This impressive growth is an outcome of a series of sound legis...

The U.S. Food and Drug Administration has classified Abbott’s recall of the FreeStyle Libre, Libre 14 day, and Libre 2 Flash continuous glucose monitoring system (CGM) readers as a Class I recall...

A sign of change is showing in the Korean diabetes treatment market, sized at 1 trillion won ($760 million). The catalyst of change is the provision of insurance benefits for the combined use of DP...

Johnson & Johnson (J&J) has said it is offering $8.9bn to resolve the tens of thousands of lawsuits it faces in North America that claim its talc-based products cause cancer. ...

Sartorius has said it will acquire Polyplus for around €2.4bn from private investors to bolster its activities supplying cell and gene therapy companies.

The companies will jointly identify molecular glue degraders against multiple therapeutic targets Merck.

The designation helps the firm accelerate the development and evaluation of CB-011.

The EUA is backed by data obtained from the multicentre Phase III PANAMO trial.